Zdrowie i gospodarka · 10/12/2004

FDA Classifies Implantable Radiofrequency Transponder System for Patient Identification and Health Information

The US Food and Drug Administration (FDA) has classified the implantable radiofrequency transponder system, used for patient identification and health information, into Class II, requiring special controls to ensure its safety and effectiveness, as outlined in the new guidance document.